Nishadil
Signup Signin
Delhi | 25°C (windy)
The Whisper of an Exit: What Jack Kaye's uniQure Stock Sale Could Tell Us

The Whisper of an Exit: What Jack Kaye's uniQure Stock Sale Could Tell Us
The FDA's Tightening Grip: A Crucible for Biotech's Biggest Bets

The FDA's Tightening Grip: A Crucible for Biotech's Biggest Bets
uniQure's Explosive 248% Rally: Why Wall Street Believes the Best is Yet to Come

uniQure's Explosive 248% Rally: Why Wall Street Believes the Best is Yet to Come
Biotech Sensation: uniQure's Huntington's Breakthrough Fuels Historic Stock Surge

Biotech Sensation: uniQure's Huntington's Breakthrough Fuels Historic Stock Surge
A New Horizon of Hope: uniQure's AMT-130 Shines with Positive 3-Year Data in Huntington's Disease

A New Horizon of Hope: uniQure's AMT-130 Shines with Positive 3-Year Data in Huntington's Disease
A Beacon of Hope: uniQure's AMT-130 Gene Therapy Shines in Huntington's Disease Trial

A Beacon of Hope: uniQure's AMT-130 Gene Therapy Shines in Huntington's Disease Trial
Load more..